Delivery Order SPE2DB20D3103-SPE2DB25FP8P5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitive delivery order, with a ceiling value of $1,066.35 and firm fixed pricing, represents a continuation of the contractor's pharmaceutical supply services to federal military and healthcare systems. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,016.67 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 for a ceiling value of $1,949.17. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed pricing and is scheduled for completion by August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $3,663.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for cefpodoxime 200 mg tablets (20-count) with a completion date of September 2, 2025. This contract is classified as a non-set-aside award, meaning it was competitively awarded without restrictions on eligible bidders. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.48 to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefpodoxime 200 mg tablets in quantities of 20 tablets, with a ceiling value of $2,615.55. The contract, awarded on August 13, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of August 14, 2025. This award was not set-aside and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for cefpodoxime 200 mg tablets (20-count units) with a ceiling value of $2,252.00. This firm fixed-price delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,672.34 to AmerisourceBergen Drug Corp for Cefpodoxime 200 mg tablets in quantities of 20 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.27 to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of April 22, 2025, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a $1,184.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20 tablets of Cefpodoxime 200 mg, an oral antibiotic commonly used to treat bacterial infections. This non-set-aside delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger prime indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8P5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cefpodoxime 100 mg tablets in quantities of 20 units, with a contract value of $3,668.40. This non-competitive, firm fixed price delivery order is set to conclude by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.999 billion through December 2026. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's consistent selection for such procurements reflects its established capability to meet federal medical supply requirements and support the Defense Health Agency and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/13/25 |